| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.086 | 0.01 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.16 | 0.01 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.01 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.01 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.01 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.071 | 0.01 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.096 | 0.01 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.12 | 0.02 |